Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.
Publication
, Conference
Peters, KB; Kirkpatrick, J; Batinic-Haberle, I; Affronti, ML; Woodring, S; Iden, D; Lipp, ES; Healy, P; Herndon, JE; Boyd, K; Hahn, K; Gad, S ...
Published in: Supportive Care in Cancer
2020
MASCC20-ABS-1534
Duke Scholars
Published In
Supportive Care in Cancer
ISSN
0941-4355
Publication Date
2020
Location
Seville, Spain
Publisher
Springer (part of Springer Nature)
Conference Name
2020 MASCC/ISOO Annual Meeting
Related Subject Headings
- Oncology & Carcinogenesis
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Kirkpatrick, J., Batinic-Haberle, I., Affronti, M. L., Woodring, S., Iden, D., … Crapo, J. (2020). Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. In Supportive Care in Cancer. Seville, Spain: Springer (part of Springer Nature).
Peters, Katherine B., John Kirkpatrick, I. Batinic-Haberle, Mary L. Affronti, Sarah Woodring, Deborah Iden, Eric S. Lipp, et al. “Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.” In Supportive Care in Cancer. Springer (part of Springer Nature), 2020.
Peters KB, Kirkpatrick J, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, et al. Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. In: Supportive Care in Cancer. Springer (part of Springer Nature); 2020.
Peters, Katherine B., et al. “Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.” Supportive Care in Cancer, Springer (part of Springer Nature), 2020.
Peters KB, Kirkpatrick J, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, Lipp ES, Healy P, Herndon JE, Boyd K, Hahn K, Spasojevic I, Gad S, Silberstein D, Johnson MO, Randazzo D, Desjardins A, Friedman HS, Ashley D, Crapo J. Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. Supportive Care in Cancer. Springer (part of Springer Nature); 2020.
Published In
Supportive Care in Cancer
ISSN
0941-4355
Publication Date
2020
Location
Seville, Spain
Publisher
Springer (part of Springer Nature)
Conference Name
2020 MASCC/ISOO Annual Meeting
Related Subject Headings
- Oncology & Carcinogenesis
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences